Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi, Tanzania, and Zambia
- PMID: 16601659
- PMCID: PMC2743105
- DOI: 10.1097/01.olq.0000216029.00424.ae
Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi, Tanzania, and Zambia
Abstract
Objectives: The objectives of this cross-sectional study were to determine correlates of syphilis seroprevalence among HIV-infected and -uninfected antenatal attendees in an African multisite clinical trial, and to improve strategies for maternal syphilis prevention.
Results: A total of 2,270 (86%) women were HIV-infected and 366 (14%) were HIV-uninfected. One hundred seventy-five (6.6%) were syphilis-seropositive (7.3% among HIV-infected and 2.6% HIV-uninfected women). Statistically significant correlates included geographic site (odds ratio [OR] = 4.5, Blantyre; OR = 3.2, Lilongwe; OR = 9.0, Lusaka vs. Dar es Salaam referent); HIV infection (OR = 3.3); age 20 to 24 years (OR = 2.5); being divorced, widowed, or separated (OR = 2.9); genital ulcer treatment in the last year (OR = 2.9); history of stillbirth (OR = 2.8, one stillbirth; OR = 4.3, 2-5 stillbirths); and history of preterm delivery (OR = 2.7, one preterm delivery).
Conclusion: Many women without identified risk factors were syphilis-seropositive. Younger HIV-infected women were at highest risk. Universal integrated antenatal HIV and syphilis screening and treatment is essential in sub-Saharan African settings.
References
-
- Ament LA, Whalen E. Sexually transmitted diseases in pregnancy: Diagnosis, impact, and intervention. J Obstet Gynecol Neonatal Nurs. 1996;25:657–666. - PubMed
-
- Pao D, Goh BT, Bingham JS. Management issues in syphilis. Drugs. 2002;62:1447–1461. - PubMed
-
- Watson-Jones D, Changulacha J, Gumodoka B, et al. Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis. 2002;186:940–947. - PubMed
-
- Brocklehurst P. Update on the treatment of sexually transmitted infections in pregnancy—1. Int J STD AIDS. 1999;10:571–580. - PubMed
Publication types
MeSH terms
Grants and funding
- N01 AI045200/AI/NIAID NIH HHS/United States
- U01-AI-48005/AI/NIAID NIH HHS/United States
- U01-AI-480006/AI/NIAID NIH HHS/United States
- U01 AI048006/AI/NIAID NIH HHS/United States
- U01 AI048005/AI/NIAID NIH HHS/United States
- 1 F31 HD 046415-01/HD/NICHD NIH HHS/United States
- F31 HD046415/HD/NICHD NIH HHS/United States
- U01 AI047972/AI/NIAID NIH HHS/United States
- D43 TW001035/TW/FIC NIH HHS/United States
- N01-AI-35173-117/412/AI/NIAID NIH HHS/United States
- D43 TW01035-07/TW/FIC NIH HHS/United States
- N01 AI035173/AI/NIAID NIH HHS/United States
- U01-AI-47972/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical